Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPVX: HPV (NO BRAND NAME) / UNKNOWN MANUFACTURER||- / 2||- / -|
Administered by: Unknown Purchased by: ??
Symptoms: Condition aggravated, Death, Systemic lupus erythematosus
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Current Illness: Lupus erythematosus
Diagnostic Lab Data:
CDC 'Split Type': CO0095075131909COL011382
Write-up: Erythematosus lupus empeoring; This spontaneous report was received from a regulatory authority and refers to a 16 (units not provided) female patient. There was no information about the patient''s concomitant therapies or medical history provided. Her concurrent conditions included lupus erythematosus. On an unknown date, the patient was vaccinated with quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (manufacturer unknown) (second dose, frequency, route of administration, anatomical location, lot # and expiration date were not provided) for prophylaxis. On an unknown date, the patient experienced worsening of lupus erythematosus and died due to it on an unknown date. It was unknown if autopsy was performed. The relatedness between the event and quadrivalent human papillomavirus (types 6,11,16,18) recomb. Vaccine (manufacturer unknown) was reported as possible.; Reported Cause(s) of Death: Systemic lupus erythematosus
Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166